Prime Biosciences
Prime Biosciences is a Greece-based B2B healthcare distributor and market-entry partner for international manufacturers, supplying point-of-care diagnostics, food supplements, and cosmetics to healthcare providers across Eastern and Southern Europe.
- Company typePrivate
- Founded2018
- HeadquartersÁgios Dimítrios, Greece
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Prime Biosciences does
Prime Biosciences is a Greece-based B2B healthcare distribution and market-entry company founded in 2018 that represents and distributes high-specification medical products across Eastern and Southern Europe. Operating as an intermediary between international pharmaceutical and medical-device manufacturers and regional healthcare providers, the company covers therapeutic areas including pediatrics, intensive care, infectious disease, orthopedics, and allergology. Its core supplier relationships include Abionic (abioSCOPE nanofluidic platform and PSP IVD capsules), Lumos Diagnostics (FebriDx), Lyfstone (calprotectin PJI test), and Svar Life Science (CalproSmart). The company is headquartered in Agios Dimitrios, Athens, holds an MDR EUDAMED importer registration, and operates under multiple ISO certifications.
The product portfolio spans three categories. Diagnostics include point-of-care tests for early sepsis detection (PSP/abioSCOPE, FDA 510(k) cleared, EU IVDR certified), differentiation of viral from bacterial respiratory infection (FebriDx), periprosthetic joint infection (Lyfstone Calprotectin), and inflammatory bowel disease monitoring (CalproSmart with mobile integration). Food supplements, marketed under the Ingenic sub-brand, include patented carbonyl iron formulations (Ingenic Iron MAX, Ingenic Junior Iron) and pediatric D3+K2 and lactase enzyme products. Cosmetics were added in May 2025 with Halibut Repairing Ointment (miconazole + zinc oxide), marking entry into dermocosmetics. Notable performance claims include sepsis detection 24-72 hours earlier than standard care, 99% negative predictive value for FebriDx, and 98.1%/95.7% sensitivity/specificity for Lyfstone Calprotectin.
The business model combines product distribution margins with professional market-entry services for partner manufacturers. Revenue is generated by representing and distributing partner-developed products through pharmaceutical warehouses and logistics partners, supported by direct field sales to hospitals and clinics and recurring engagement with healthcare professionals via medical conference sponsorships, satellite lectures, and KOL collaborations. Marketing is concentrated on scientific engagement channels—Pan-European congress sponsorships, satellite symposia, the company website, and LinkedIn/Facebook presence—rather than mass-market advertising. The company is privately held with no disclosed funding rounds or institutional investors.
Prime Biosciences firmographics
Firmographics- Name
- Prime Biosciences
- Legal name
- PRIME BIOSCIENCES P.C.
- Website
- https://primebiosciences.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Prime Biosciences is a Greece-based B2B healthcare distributor and market-entry partner for international manufacturers, supplying point-of-care diagnostics, food supplements, and cosmetics to healthcare providers across Eastern and Southern Europe.
- Ownership category
- akta.pro rank
Prime Biosciences industry classification
Industry- Product category
- Medical Product Distribution and Representation
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)
- akta.pro secondary industry
- Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)
Keywords
Where Prime Biosciences is headquartered
LocationHeadquarters
- HQ city
- Ágios Dimítrios
- HQ country
- Greece
- HQ region
- Europe
Offices1 record
Markets served
Prime Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Marketing or Sales, Operations, Others
Revenue model
- Product Distribution & Representation: Prime Biosciences distributes and represents high-specification medical products including diagnostics, food supplements, cosmetics, and medical devices. They work with partners to strengthen market presence and share in local markets.
- Market Entry Services: For each new product they represent, they create personalized product plans including market research and analysis, marketing and sales execution, and product distribution coordination with pharma warehouses.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Prime Biosciences product offering
Product offeringCore offering
Prime Biosciences is a B2B distributor and representative of high-specification medical products including point-of-care diagnostics (sepsis, respiratory infection, PJI, IBD), food supplements, cosmetics, and medical devices. The company creates personalized product launch plans for partner products that include market research, marketing and sales execution, and product distribution. It operates as a market entry partner for international pharmaceutical and medical device companies targeting Eastern and Southern European markets, supported by collaborations with pharmaceutical companies, medical suppliers, healthcare professionals, and key opinion leaders.
Product overview
Prime Biosciences offers a portfolio of medical products and services in the healthcare industry, organized into three main categories: Diagnostics (including PSP/abioSCOPE®, FebriDx®, Lyfstone® Calprotectin, and CalproSmart), Food Supplements (including Delictase®, Ingenic® Junior D3+K2, Ingenic® Junior Iron, and Ingenic® Iron MAX under the Ingenic sub-brand), and Cosmetics (Halibut Repairing ointment). The company operates across therapeutic areas including pediatrics, intensive care, infectious disease, orthopedics, and allergology, providing products ranging from point-of-care diagnostic devices to dietary supplements and dermocosmetics.
Differentiator
Problem solved
Functional benefit
Brands
- Ingenic: A sub-brand of Prime Biosciences offering innovative and high-quality food supplements to the Greek market, including products like Ingenic Iron MAX, Ingenic junior Iron, and Ingenic junior D3+K2.
Products and services
- PSP / abioSCOPE® Point-of-care in vitro diagnostic device that measures Pancreatic Stone Protein (PSP) for early sepsis detection. Uses patented nanofluidic technology to analyze up to 14 parameters from a single drop of blood, providing results in 5 minutes and detecting sepsis 24-72 hours earlier than standard care. Targeted at hospital and critical care settings.
- FebriDx® Rapid all-in-one point-of-care test that differentiates viral from bacterial acute respiratory infections by measuring CRP and MxA biomarkers. Provides results in 10 minutes using 5 µL of fingerstick blood with 99% negative predictive value. Intended for clinicians managing patients with acute respiratory infections.
- Lyfstone® Calprotectin CE-IVD rapid test for periprosthetic joint infection (PJI) diagnosis. Measures calprotectin in synovial fluid, requiring only 20 µL and providing results in 15 minutes with 98.1% sensitivity and 95.7% specificity. Used by orthopedic specialists in joint infection workup.
- CalproSmart Quantitative rapid test for fecal calprotectin measurement, used in diagnosing inflammatory bowel disease (IBD) and differentiating it from irritable bowel syndrome (IBS). Provides results in 18 minutes with mobile app integration (Android, iPhone) for automatic communication of results to treating physicians via web portal.
- Delictase® Food supplement containing lactase enzyme for breakdown and absorption of lactose. Used for infant colic relief and management of gastroenteritis/diarrhea by stopping osmotic diarrhea during gastrointestinal infections.
- Ingenic® Junior D3+K2 Food supplement spray providing vitamins D3 and K2 for healthy development of children. Vitamin D3 supports immune system and bone health; vitamin K2 aids calcium absorption and blood coagulation. Sold under the Ingenic sub-brand.
- Ingenic® Junior Iron Innovative patented food supplement containing carbonyl iron in oral solution with MCT oil for children. Supports normal cognitive development and red blood cell formation with neutral taste and excellent safety profile.
- Ingenic® Iron MAX Innovative patented food supplement containing carbonyl iron (98% elemental iron with 69% bioavailability) in oral solution with MCT oil and GRAS safety certification. Suitable for the whole family including pregnant women and elderly, with no metallic taste, constipation, or tooth discoloration.
- Halibut Repairing Ointment combining 0.25% miconazole with zinc oxide for protection and treatment of skin conditions. Offers antifungal, healing and regenerative action without systemic absorption. Suitable for all ages (0+) including infants, for intertrigo, diaper rash, eczema, athlete's foot, and dermatophytosis.
- Medical Product Distribution and Representation Services Market entry and distribution services for international pharmaceutical, biotech, and medical device manufacturers targeting Eastern and Southern Europe. Services include personalized product launch plans, market research and analysis, marketing and sales execution, and coordination with pharmaceutical warehouses for product distribution.
Quantifiable outcome
- PSP test detects sepsis 24-48 hours earlier than current standards, up to 72 hours before standard of care
- +3 more outcomes
Companies that use Prime Biosciences
Customer profileSegments3 records
Ideal customer profiles2 records
Prime Biosciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Prime Biosciences partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and secondary.
- Abionic (abioSCOPE)coreAbionic provides the abioSCOPE device and PSP IVD Capsules for rapid sepsis detection. Prime Biosciences distributes these products in their market region. The PSP test has received FDA 510(k) clearance and EU IVDR certification.
- LyfstonecoreLyfstone provides the Calprotectin test for periprosthetic joint infection detection. The CE-IVD test delivers results in 15 minutes with 98.1% sensitivity.
- FebriDx (Lumos Diagnostics)coreFebriDx is distributed by Prime Biosciences - a rapid POC test differentiating viral from bacterial infections using dual biomarkers CRP and MxA.
- Svar Life Science (CalproSmart)secondarySvar Life Science provides CalproSmart - a rapid test for fecal calprotectin measurement with mobile app integration for IBD monitoring.
- HayMaxsecondaryHayMax is a medical device product represented by Prime Biosciences.
- CalmarksecondaryCalmark is a product partner represented by Prime Biosciences.
- NeosantesecondaryNeosante is a product partner represented by Prime Biosciences.
- Largest Pharmaceutical Warehouses & Distribution CompaniescorePrime Biosciences collaborates with the largest pharma warehouses and logistics companies to ensure safe and timely distribution of products across their market region.
- Key Opinion Leaders (KOLs)corePrime Biosciences identifies and consults with Key Opinion Leaders in the medical community for market analysis and product positioning.
Scale indicators4 records
Recent moves2 records
Expansion highlights4 records
Prime Biosciences competitors and assessment
Company assessmentBroad incumbents
- McKesson Corporation: McKesson is the largest pharmaceutical distributor in North America with extensive European medical distribution operations. Comparable to Prime Biosciences as a global pharma and medical product distributor serving the same end customers (pharmacies, hospitals, clinicians) at much greater scale and geographic breadth.
- Cardinal Health: Cardinal Health is a major global medical products distributor with pharmaceutical and medical surgical segments serving hospitals, pharmacies, and clinical laboratories. Comparable to Prime Biosciences as a broad medical product wholesaler, though Cardinal Health operates at vastly greater scale and across all major European and US markets.
- Henry Schein, Inc. Henry Schein is a global distributor of healthcare products and services to physician offices, dental practices, animal health, and ambulatory surgery centers. Comparable to Prime Biosciences as a specialty medical product distributor, though Henry Schein operates across many more geographies and product categories at significantly larger scale.
Direct peers
- Help Pharmaceuticals: Help Pharmaceuticals is a Greek pharmaceutical company focused on the development, manufacturing, and distribution of branded generics and consumer health products. Highly comparable to Prime Biosciences as a Greek-headquartered pharma distributor serving pharmacy and hospital channels with specialty products.
- Pharmathen S.A. Pharmathen is one of the largest Greek pharmaceutical companies, specializing in the development, manufacturing, and global distribution of generics and complex generics. Comparable to Prime Biosciences as a Greek-headquartered pharma distributor with international partner representation and EU regulatory expertise.
- Elpen Pharmaceutical Co. Inc. Elpen is a Greek pharmaceutical company manufacturing and distributing branded generics and consumer health products, with strong presence in respiratory and cardiovascular categories. Comparable to Prime Biosciences as a Greek-based pharma and parapharmaceutical distributor with overlapping specialty portfolio and Greek/EU footprint.
- Genesis Pharma: Genesis Pharma is a Greek specialty pharmaceutical company that represents and distributes innovative biopharmaceutical products from international partners in Greece and Cyprus. Highly comparable to Prime Biosciences' representation/distribution model for international pharma and diagnostic principals in Eastern/Southern Europe.
- Vianex S.A. Vianex is one of the largest Greek pharmaceutical companies, manufacturing and distributing branded and generic medicines, parapharmaceuticals, and medical devices in Greece and international markets. Directly comparable to Prime Biosciences as a Greek-headquartered pharma and medical products distributor with overlapping therapeutic areas and a similar B2B sales motion.
- Demo S.A. Pharmaceutical Industry: Demo is a leading Greek pharmaceutical manufacturer and distributor operating across injectables, hospital, and consumer health categories with international export reach. Comparable to Prime Biosciences in serving Greek and Southeastern European healthcare channels with specialty medical and parapharmaceutical products.
- Unipharma S.A. Unipharma is a Greek pharmaceutical distribution and logistics company supplying medicines and parapharmaceuticals to pharmacies across Greece. Comparable to Prime Biosciences as a Greek pharma distributor operating in adjacent therapeutic areas through wholesale and channel partnerships.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Prime Biosciences social profiles
Digital presencePrime Biosciences compliance and trust
Trust signalCompliance6 records
Prime Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Prime Biosciences leadership team
Management profileNumber of profiles
Prime Biosciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Prime Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Prime Biosciences
What does Prime Biosciences do?
Prime Biosciences is a B2B distributor and representative of high-specification medical products including point-of-care diagnostics (sepsis, respiratory infection, PJI, IBD), food supplements, cosmetics, and medical devices. The company creates personalized product launch plans for partner products that include market research, marketing and sales execution, and product distribution. It operates as a market entry partner for international pharmaceutical and medical device companies targeting Eastern and Southern European markets, supported by collaborations with pharmaceutical companies, medical suppliers, healthcare professionals, and key opinion leaders.
Is Prime Biosciences a public or private company?
Prime Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Prime Biosciences founded?
Prime Biosciences was founded in 2018. It employs 11 to 50 people.
Where is Prime Biosciences based?
Prime Biosciences is headquartered in Ágios Dimítrios, Greece, in the Europe region.
How does Prime Biosciences make money?
Two revenue lines are on record. Product Distribution & Representation is the primary driver. The others are market Entry Services.
Who are Prime Biosciences's main competitors?
Broad incumbents on record are McKesson Corporation, Cardinal Health and Henry Schein, Inc.. Direct peers are Help Pharmaceuticals, Pharmathen S.A., Elpen Pharmaceutical Co. Inc., Genesis Pharma, Vianex S.A., Demo S.A. Pharmaceutical Industry and Unipharma S.A..
Does Prime Biosciences have an API?
No public API is recorded for Prime Biosciences.
What industry is Prime Biosciences in?
Prime Biosciences's product category is Medical Product Distribution and Representation. Its primary akta.pro industry code is HLAIAJAO, Compounding Ingredient & API Distributors (Pharma Supply), with a secondary code of HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 424210 and its SIC code is 5122.